Advanced search×

Molecular profiling of heart endothelial cells.

Lianglin L Zhang, Jason A JA Hoffman, and Erkki E Ruoslahti

Audio, Transactions of the IRE Profess... 112(11):1601-11 (2005) PMID 16144998

Endothelial cells that line the vascular lumen can express cell-surface proteins that are specific to the endothelium of a particular tissue. In this study, we probed the heart vasculature for heart-specific endothelial markers by phage display.

DOI: 10.1161/CIRCULATIONAHA.104.529537
Version: za2963e q8za9 q8zbb q8zc9 q8zdb q8ze7 q8zfe q8zg9

Similar articles you may find interesting…

  1. Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma.
    Valentina Fogal, Lianglin Zhang, ... Erkki Ruoslahti

    Cancer Res 68(17):7210-8 (2008) PMID 18757437

    We show that the protein known as p32 or gC1q receptor is the receptor for LyP-1. Various human tumor cell lines were positive for p32 expression in culture, and the expression was increased in xenograft tumors grown from the positive cell lines. Fluorescence-activated cell sorting analyses with ant...
  2. A database of IC50 values and principal component analysis of results from six basal cytotoxicity assays, for use in the modelling of the in...
    Richard R Clothier, Paul P Dierickx, ... Roel R Anthonissen

    Altern Lab Anim 36(5):503-19 (2008) PMID 19025321

    The main aim of the ACuteTox project (part of the EU 6th Framework programme) is to demonstrate that animal tests for acute systemic toxicity can be replaced by alternative in vitro assays. In this project, data for 97 reference chemicals were collected in the AcuBase database, designed to handle de...
  3. Identification and characterization of peptides that bind human ErbB-2 selected from a bacteriophage display library.
    Natalia G NG Karasseva, Vladislav V VV Glinsky, ... Thomas P TP Quinn

    J Protein Chem 21(4):287-96 (2002) PMID 12168699

    The ErbB-2 receptor, a member of the tyrosine kinase type 1 family of receptors, has been implicated in many human malignancies. The overexpression of ErbB-2 in cancer cells as well as its extracellular accessibility makes it an attractive target for the development of tumor-specific agents. In this...